Gabriel G. Matus

Gabriel Matus is an attorney in the Corporate Practice Group in the firm's New York office.

Mr. Matus regularly counsels public and private companies in connection with mergers and acquisitions, corporate finance, joint ventures, executive compensation, corporate governance and a variety of securities law issues.  Mr. Matus has also been involved in various distressed asset matters, including bankruptcy-related restructurings and dispositions.  Mr. Matus currently serves as a member of the New York State Bar Association's Committee on Securities Regulation.

Mr. Matus also counsels boards of directors of several not-for-profit corporations, including Aid for AIDS International, Inc., on corporate governance, finance and other corporate issues.

Education

• J.D., New York Law School, cum laude, 2000
• B.A., University of Maryland, Dean's List, 1996

Admissions

• New York

Representative M&A transactions:

• Blue & White Food Products Corp. in the sale of its 49% joint venture interest in the Sabra^TM dips and spreads business
• Hollywood Media Corp. in the $35 million sale of its Baseline division to The New York Times Company
• CBS Corporation in its $325 million acquisition of CSTV Networks, Inc.
• L-1 Identity Solutions, Inc. in its $35 million acquisition of Iridian Technologies, Inc.

Representative Corporate Finance and Lending Transactions:

• FirmGreen, Inc. in its development equity/debt financing and related licensing matters for landfill gas extraction projects

• Kratos Defense and Security Solutions, Inc. in its $85 million acquisition financing for the purchase of Haverstick Consulting, Inc.

Representative Restructuring matters:

• Counseling various financial institutions and other counterparties to Lehman Brothers derivative contracts in connection with Lehman bankruptcy proceedings.
• The restructuring of Enron Corp.'s North American pipeline business and the formation of CrossCountry Energy, LLC.
• The sale of CrossCountry Energy, LLC to NuCoastal LLC for approximately $2.2 billion.
• IMPATH Inc.'s sale of Medical Registry Services Inc. and Tamtron Corporation to IMPAC Medical Systems, Inc. for approximately $22 million.
• IMPATH Inc.'s sale of IMPATH Physician Services, Inc. and IMPATH Predictive Oncology, Inc. to Genzyme Corporation for approximately $215 million.

Memberships

• Honorary Advisory Board, Aid for AIDS International, Inc.
• Board of Directors, Friends of Africa International, Inc.
• Board of Directors, Seeds of Solutions, Inc.
• Member, New York State Bar Association - Securities Regulation Committee, Committee on Professional Discipline and Corporations Law Committee's subcommittee on Not-for-Profit Corporations
• Member, Hispanic National Bar Association

Articles

"Not So Big MAC, Don't Count on the Credit Crunch to Get You Out Of a Bad Deal" The Daily Deal, November 19, 2007 (Co-author)

"The Regulation of Alternative Trading Systems: Market Fragmentation and the New Market Structure," New York Law School Law Review, Vol. 44 (2001)

Corporate & Securities Law Blog Articles

• "The Importance of Well-Crafted MAE Provisions: Sallie Mae in Courtroom Battle with J.C. Flowers-led Buyout Group", October 24, 2007

Press

• "Sheppard Mullin Lauded By AID for AIDS International", December 2, 2008

Hispanic/Latino Newsletter

• Enfoque Latino - Spring 2008